0001883850-22-000072.txt : 20221003
0001883850-22-000072.hdr.sgml : 20221003
20221003160544
ACCESSION NUMBER: 0001883850-22-000072
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220929
FILED AS OF DATE: 20221003
DATE AS OF CHANGE: 20221003
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tessier-Lavigne Marc
CENTRAL INDEX KEY: 0001437435
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 221287523
MAIL ADDRESS:
STREET 1: 1 DNA WAY
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2022-09-29
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001437435
Tessier-Lavigne Marc
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
1
0
0
0
Common Stock
2022-09-29
4
M
0
3798
413.33
A
6067
D
Common Stock
2022-09-29
4
S
0
16
686.89
D
6051
D
Common Stock
2022-09-29
4
S
0
321
687.9
D
5730
D
Common Stock
2022-09-29
4
S
0
637
688.71
D
5093
D
Common Stock
2022-09-29
4
S
0
1009
689.56
D
4084
D
Common Stock
2022-09-29
4
S
0
692
690.65
D
3392
D
Common Stock
2022-09-29
4
S
0
554
691.59
D
2838
D
Common Stock
2022-09-29
4
S
0
85
696.13
D
2753
D
Common Stock
2022-09-29
4
S
0
160
697.29
D
2593
D
Common Stock
2022-09-29
4
S
0
208
698.44
D
2385
D
Common Stock
2022-09-29
4
S
0
80
699.82
D
2305
D
Common Stock
2022-09-29
4
S
0
16
702.36
D
2289
D
Common Stock
2022-09-29
4
S
0
20
704.83
D
2269
D
Common Stock
2022-09-30
4
M
0
3428
413.33
A
5697
D
Common Stock
2022-09-30
4
S
0
3428
698.0
D
2269
D
Common Stock
2022-10-03
4
M
0
3612
413.33
A
5881
D
Common Stock
2022-10-03
4
S
0
3612
718.0
D
2269
D
Non-Qualified Stock Option (right to buy)
413.33
2022-09-29
4
M
0
3798
0.0
D
2025-01-02
Common Stock
3798
7040
D
Non-Qualified Stock Option (right to buy)
413.33
2022-09-30
4
M
0
3428
0.0
D
2025-01-02
Common Stock
3428
3612
D
Non-Qualified Stock Option (right to buy)
413.33
2022-10-03
4
M
0
3612
0.0
D
2025-01-02
Common Stock
3612
0
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 16 shares of Company stock on September 29, 2022 at prices ranging from $686.89 to $686.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 29, 2022 at each separate price.
Represents volume-weighted average price of sales of 321 shares of Company stock on September 29, 2022 at prices ranging from $687.05 to $687.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 29, 2022 at each separate price.
Represents volume-weighted average price of sales of 637 shares of Company stock on September 29, 2022 at prices ranging from $688.08 to $688.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 29, 2022 at each separate price.
Represents volume-weighted average price of sales of 1,009 shares of Company stock on September 29, 2022 at prices ranging from $689.07 to $689.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 29, 2022 at each separate price.
Represents volume-weighted average price of sales of 692 shares of Company stock on September 29, 2022 at prices ranging from $690.06 to $690.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 29, 2022 at each separate price.
Represents volume-weighted average price of sales of 554 shares of Company stock on September 29, 2022 at prices ranging from $691.29 to $691.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 29, 2022 at each separate price.
Represents volume-weighted average price of sales of 85 shares of Company stock on September 29, 2022 at prices ranging from $696.03 to $696.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 29, 2022 at each separate price.
Represents volume-weighted average price of sales of 160 shares of Company stock on September 29, 2022 at prices ranging from $697.10 to $697.66. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 29, 2022 at each separate price.
Represents volume-weighted average price of sales of 208 shares of Company stock on September 29, 2022 at prices ranging from $698.19 to $698.71. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 29, 2022 at each separate price.
The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
/s/**Marc Tessier-Lavigne
2022-10-03